Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease (Q84078764)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

31 January 2020

main subject

1 reference

1 reference

1 reference

Mary P McGowan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

Current treatment options in cardiovascular medicine

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

289-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome

31 January 2020

cites work

1 reference

12 December 2020

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome

1 reference

12 December 2020

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

1 reference

12 December 2020

Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial

1 reference

12 December 2020

1 reference

12 December 2020

Mechanism of action of niacin

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?

1 reference

12 December 2020

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

1 reference

12 December 2020

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial

1 reference

12 December 2020

Menstrual cycle irregularity and risk for future cardiovascular disease

1 reference

12 December 2020

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome

1 reference

12 December 2020

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

12 December 2020

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

1 reference

12 December 2020

Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

12 December 2020

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery

1 reference

12 December 2020

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

1 reference

12 December 2020

The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.

1 reference

12 December 2020

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

1 reference

12 December 2020

Cost-effectiveness of bariatric surgery for severely obese adults with diabetes

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights

1 reference

12 December 2020

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1 reference

12 December 2020

Standards of medical care in diabetes--2010.

1 reference

12 December 2020

Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Trends and outcomes of adolescent bariatric surgery in California, 2005-2007.

1 reference

12 December 2020

Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

1 reference

12 December 2020

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects

1 reference

12 December 2020

10.1007/S11936-011-0130-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21562798%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference